FimH mannoside antagonists (GSK/Fimbrion)

N/A

Report date: 2025/06/11 11:06:10
NME

Base Information

Drug NameFimH mannoside antagonists (GSK/Fimbrion)
Drug Alias NameGSK-9747GSK-3859747A
ClassificationSmall molecules
Mechanisms of ActionType 1 fimbrin D-mannose specific adhesin inhibitors
TargetsType 1 fimbrin D-mannose specific adhesin
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesFimbrion Therapeutics IncGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A